The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report

Venetoclax combined with hypomethylating agents such as azacitidine and decitabine is the standard regime for the elderly patient with acute myeloid leukemia (AML) unfit for intensive induction therapy. However, many patients struggle with finances and forgo treatments due to the high costs of venet...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Zhangbiao, Ruan, Min, Wu, Wei, Zeng, Qingshu, Li, Qingsheng, Huang, Zhengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554551/
https://www.ncbi.nlm.nih.gov/pubmed/36248996
http://dx.doi.org/10.3389/fonc.2022.912696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554551/
https://www.ncbi.nlm.nih.gov/pubmed/36248996
http://dx.doi.org/10.3389/fonc.2022.912696

Ejemplares similares